Veru (VERU) Receivables (2010 - 2024)
Veru (VERU) posted quarterly Receivables of $4.0 million for Q3 2024, down 53.11% year-over-year from $8.4 million in Q4 2023, and up 141.18% quarter-over-quarter from $1.6 million in Q2 2024.
Veru (VERU) Receivables (2010 - 2024) Analysis & Trends
Veru (VERU) has reported Receivables for 15 consecutive years, with $4.0 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Receivables fell 53.11% year-over-year to $4.0 million; the TTM figure through Sep 2024 stood at $4.0 million (down 53.11% YoY), while the FY2024 annual figure was $4.0 million, down 53.11% from the prior year.
- Receivables improved to $4.0 million in Q3 2024 per VERU's latest filing, from $1.6 million in the prior quarter.
- Across five years, Receivables topped out at $13.4 million in Q2 2021 and bottomed at $1.6 million in Q2 2024.
- Historically, Receivables has averaged $6.6 million across 5 years, with a median of $6.7 million in 2024.
- Annual changes were most pronounced in 2021 — Receivables surged 166.78% — and 2024, when it sank 81.81%.
- Veru's Receivables stood at $6.7 million in 2020, then increased by 21.27% to $8.1 million in 2021, then sank by 51.83% to $3.9 million in 2022, then sank by 38.71% to $2.4 million in 2023, then surged by 66.19% to $4.0 million in 2024.
- Business Quant data shows VERU's Receivables at $4.0 million in Q3 2024, $1.6 million in Q2 2024, and $6.7 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | - |
| 10 | Veru | 61.03 Mn | 35.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 6.72 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Sep 30, 2023 | 8.45 Mn |
| Jun 30, 2023 | 9.03 Mn |
| Mar 31, 2023 | 8.14 Mn |
| Dec 31, 2022 | 3.89 Mn |
| Sep 30, 2022 | 3.55 Mn |
| Jun 30, 2022 | 8.30 Mn |
| Mar 31, 2022 | 8.13 Mn |
| Dec 31, 2021 | 8.07 Mn |
| Sep 30, 2021 | 8.79 Mn |
| Jun 30, 2021 | 13.44 Mn |
| Mar 31, 2021 | 7.65 Mn |
| Dec 31, 2020 | 6.66 Mn |
| Sep 30, 2020 | 5.33 Mn |
| Jun 30, 2020 | 5.04 Mn |
| Mar 31, 2020 | 5.80 Mn |
| Dec 31, 2019 | 6.06 Mn |